Tetraspanin CO-029 inhibits colorectal cancer cell movement by deregulating cell-matrix and cell-cell adhesions

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Guo, Qiusha ^a,b,c   Xia, Bing ^b   Zhang, Feng ^a   Richardson, Mekel M ^a   Li, Minghao ^a   Zhang, Julian S ^a   Chen, Feng ^c   Zhang, Xin A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b WUHAN UNIVERSITY   (China)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; HERMES ANTIGEN; INTEGRIN; LAMININ; PROTEIN CO 029; TETRASPANIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 5; TSPAN8 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CELL ADHESION; CELL MIGRATION; CELL MOTION; CELL STRAIN HT29; COLORECTAL CANCER; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; PROTEIN EXPRESSION; RNA INTERFERENCE; UPREGULATION; WESTERN BLOTTING; COLORECTAL TUMOR; GENETICS; METABOLISM; PHYSIOLOGY;

ANTIGENS, CD44; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; COLORECTAL NEOPLASMS; FLOW CYTOMETRY; HT29 CELLS; HUMANS; IMMUNOPRECIPITATION; INTEGRIN ALPHA3BETA1; INTEGRIN ALPHA5BETA1; LAMININ; RNA INTERFERENCE; TETRASPANINS;

EID: 84861889745     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038464     Document Type: Article

References (66)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer Statistics, 2008. CA: A Cancer Journal for Clinicians 58: 71-96.
2. Levy S, Shoham T, (2005) The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 5: 136-148.
3. Hemler ME, (2003) Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 19: 397-422.
4. Boucheix C, Duc GH, Jasmin C, Rubinstein E, (2001) Tetraspanins and malignancy. Expert Rev Mol Med 2001 1-17 pp. 1-17.
5. Nakazawa Y, Sato S, Naito M, Kato Y, Mishima K, et al. (2008) Tetraspanin family member CD9 inhibits Aggrus/podoplanin-induced platelet aggregation and suppresses pulmonary metastasis. Blood pp. blood-2007-2011-124693.
6. Mazzocca A, Liotta F, Carloni V, (2008) Tetraspanin CD81-Regulated Cell Motility Plays a Critical Role in Intrahepatic Metastasis of Hepatocellular Carcinoma. Gastroenterology 135: 244-256.e241.
7. Inoue G, Horiike N, Onji M, (2001) The CD81 expression in liver in hepatocellular carcinoma. International journal of molecular medicine 7: 67-71.
8. Pedro AL, (2007) Functional implications of tetraspanin proteins in cancer biology. Cancer Science 98: 1666-1677.
9. Kuhn S, Koch M, Nubel T, Ladwein M, Antolovic D, et al. (2007) A Complex of EpCAM, Claudin-7, CD44 Variant Isoforms, and Tetraspanins Promotes Colorectal Cancer Progression. Mol Cancer Res 5: 553-567.
10. Ovalle S, Gutiérrez-López MD, Olmo N, Turnay J, Lizarbe MA, et al. (2007) The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells. International Journal of Cancer 121: 2140-2152.
11. Zoller M, (2009) Tetraspanins: push and pull in suppressing and promoting metastasis. Nat Rev Cancer 9: 40-55.
12. Szala S, Kasai Y, Steplewski Z, Rodeck U, Koprowski H, et al. (1990) Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens. Proc Natl Acad Sci U S A 87: 6833-6837.
13. Kanetaka K, Sakamoto M, Yamamoto Y, Yamasaki S, Lanza F, et al. (2001) Overexpression of tetraspanin CO-029 in hepatocellular carcinoma. Journal of Hepatology 35: 637-642.
14. Tanaka F, Hori N, Sato K, (2002) Identification of Differentially Expressed Genes in Rat Hepatoma Cell Lines Using Subtraction and Microarray. J Biochem 131: 39-44.
15. Herlevsen M, Schmidt D-S, Miyazaki K, Zoller M, (2003) The association of the tetraspanin D6.1A with the {alpha}6{beta}4 integrin supports cell motility and liver metastasis formation. J Cell Sci 116: 4373-4390.
16. Huerta S, Harris DM, Jazirehi A, Bonavida B, Elashoff D, et al. (2003) Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis. Int J Oncol 22: 663-670.
17. Claas C, Seiter S, Claas A, Savelyeva L, Schwab M, et al. (1998) Association between the rat homologue of CO-029, a metastasis-associated tetraspanin molecule and consumption coagulopathy. J Cell Biol 141: 267-280.
18. Gesierich S, Paret C, Hildebrand D, Weitz J, Zgraggen K, et al. (2005) Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility. Clin Cancer Res 11: 2840-2852.
19. Gesierich S, Berezovskiy I, Ryschich E, Zoller M, (2006) Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029. Cancer Res 66: 7083-7094.
20. Greco C, Bralet MP, Ailane N, Dubart-Kupperschmitt A, Rubinstein E, et al. (2010) E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell motility control in human colon carcinoma. Cancer Res 70: 7674-7683.
21. Yang XH, Kovalenko OV, Kolesnikova TV, Andzelm MM, Rubinstein E, et al. (2006) Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization. J Biol Chem 281: 12976-12985.
22. Berditchevski F, Bazzoni G, Hemler ME, (1995) Specific association of CD63 with the VLA-3 and VLA-6 integrins. J Biol Chem 270: 17784-17790.
23. Serru V, Le Naour F, Billard M, Azorsa DO, Lanza F, et al. (1999) Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions. Biochem J 340 (Pt 1): 103-111.
24. He B, Liu L, Cook GA, Grgurevich S, Jennings LK, et al. (2005) Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin alpha6-mediated cell adhesion. J Biol Chem 280: 3346-3354.
25. Zhang XA, Bontrager AL, Stipp CS, Kraeft SK, Bazzoni G, et al. (2001) Phosphorylation of a conserved integrin alpha 3 QPSXXE motif regulates signaling, motility, and cytoskeletal engagement. Mol Biol Cell 12: 351-365.
26. Delwel GO, Hogervorst F, Kuikman I, Paulsson M, Timpl R, et al. (1993) Expression and function of the cytoplasmic variants of the integrin alpha 6 subunit in transfected K562 cells. Activation-dependent adhesion and interaction with isoforms of laminin. J Biol Chem 268: 25865-25875.
27. Qin Y, Capaldo C, Gumbiner BM, Macara IG, (2005) The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol 171: 1061-1071.
28. Hong IK, Jin YJ, Byun HJ, Jeoung DI, Kim YM, et al. (2006) Homophilic interactions of Tetraspanin CD151 up-regulate motility and matrix metalloproteinase-9 expression of human melanoma cells through adhesion-dependent c-Jun activation signaling pathways. J Biol Chem 281: 24279-24292.
29. Liu L, He B, Liu WM, Zhou D, Cox JV, et al. (2007) Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. J Biol Chem 282: 31631-31642.
30. Zhang XA, He B, Zhou B, Liu L, (2003) Requirement of the p130CAS-Crk coupling for metastasis suppressor KAI1/CD82-mediated inhibition of cell migration. J Biol Chem 278: 27319-27328.
31. de Both NJ, Vermey M, Dinjens WN, Bosman FT, (1999) A comparative evaluation of various invasion assays testing colon carcinoma cell lines. Br J Cancer 81: 934-941.
32. Paget S, (1989) The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8: 98-101.
33. Fidler IJ, (1987) Review: biologic heterogeneity of cancer metastases. Breast Cancer Res Treat 9: 17-26.
34. Glinsky GV, Glinsky VV, (1996) Apoptosis amd metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett 101: 43-51.
35. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I, (1996) Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol 132: 1199-1208.
36. Taichman DB, Cybulsky MI, Djaffar I, Longenecker BM, Teixido J, et al. (1991) Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell Regul 2: 347-355.
37. Mercurio AM, Rabinovitz I, (2001) Towards a mechanistic understanding of tumor invasion-lessons from the alpha6beta 4 integrin. Semin Cancer Biol 11: 129-141.
38. Mariotti A, Kedeshian PA, Dans M, Curatola AM, Gagnoux-Palacios L, et al. (2001) EGF-R signaling through Fyn kinase disrupts the function of integrin alpha6beta4 at hemidesmosomes: role in epithelial cell migration and carcinoma invasion. J Cell Biol 155: 447-458.
39. Yu Q, Stamenkovic I, (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-176.
40. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A, (2002) The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109: 987-991.
41. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G, (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193.
42. Testa JE, Brooks PC, Lin JM, Quigley JP, (1999) Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 59: 3812-3820.
43. Nishiuchi R, Sanzen N, Nada S, Sumida Y, Wada Y, et al. (2005) Potentiation of the ligand-binding activity of integrin alpha3beta1 via association with tetraspanin CD151. Proc Natl Acad Sci U S A 102: 1939-1944.
44. Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, et al. (1995) The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol 128: 929-938.
45. Iwamoto R, Higashiyama S, Mitamura T, Taniguchi N, Klagsbrun M, et al. (1994) Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J 13: 2322-2330.
46. Richardson MM, Jennings LK, Zhang XA, (2011) Tetraspanins and tumor progression. Clin Exp Metastasis 28: 261-270.
47. Szollosi J, Horejsi V, Bene L, Angelisova P, Damjanovich S, (1996) Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol 157: 2939-2946.
48. Jones PH, Bishop LA, Watt FM, (1996) Functional significance of CD9 association with beta 1 integrins in human epidermal keratinocytes. Cell Adhes Commun 4: 297-305.
49. Koyama Y, Suzuki M, Yoshida T, (1998) CD63, a member of tetraspan transmembrane protein family, induces cellular spreading by reaction with monoclonal antibody on substrata. Biochem Biophys Res Commun 246: 841-846.
50. Maecker HT, Todd SC, Levy S, (1997) The tetraspanin superfamily: molecular facilitators. FASEB J 11: 428-442.
51. Yanez-Mo M, Alfranca A, Cabanas C, Marazuela M, Tejedor R, et al. (1998) Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with alpha3 beta1 integrin localized at endothelial lateral junctions. J Cell Biol 141: 791-804.
52. Kanetaka K, Sakamoto M, Yamamoto Y, Takamura M, Kanematsu T, et al. (2003) Possible involvement of tetraspanin CO-029 in hematogenous intrahepatic metastasis of liver cancer cells. J Gastroenterol Hepatol 18: 1309-1314.
53. Sho M, Adachi M, Taki T, Hashida H, Konishi T, et al. (1998) Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 79: 509-516.
54. Sela BA, Steplewski Z, Koprowski H, (1989) Colon carcinoma-associated glycoproteins recognized by monoclonal antibodies CO-029 and GA22-2. Hybridoma 8: 481-491.
55. Boucheix C, Soria C, Mirshahi M, Soria J, Perrot JY, et al. (1983) Characteristics of platelet aggregation induced by the monoclonal antibody ALB6 (acute lymphoblastic leukemia antigen p 24). Inhibition of aggregation by ALB6Fab. FEBS Lett 161: 289-295.
56. Weinberg R, (2007) Moving out: invasion and metastasis. The biology of cancer. Chapter 14. New York Garland Science, Taylor & Francis Group, LLC; New York, NY pp. 587-654.
57. Stutzmann J, Bellissent-Waydelich A, Fontao L, Launay JF, Simon-Assmann P, (2000) Adhesion complexes implicated in intestinal epithelial cell-matrix interactions. Microsc Res Tech 51: 179-190.
58. Martin M, Simon-Assmann P, Kedinger M, Mangeat P, Real FX, et al. (2006) DCC regulates cell adhesion in human colon cancer derived HT-29 cells and associates with ezrin. Eur J Cell Biol 85: 769-783.
59. Behrens J, Mareel MM, Van Roy FM, Birchmeier W, (1989) Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 108: 2435-2447.
60. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F, (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66: 107-119.
61. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, et al. (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185.
62. Naor D, Sionov RV, Ish-Shalom D, (1997) CD44: structure, function, and association with the malignant process. Adv Cancer Res 71: 241-319.
63. Marhaba R, Zoller M, (2004) CD44 in cancer progression: adhesion, migration and growth regulation. J Mol Histol 35: 211-231.
64. Sales KM, Winslet MC, Seifalian AM, (2007) Stem cells and cancer: an overview. Stem Cell Rev 3: 249-255.
65. Zou GM, (2007) Cancer stem cells in leukemia, recent advances. J Cell Physiol 213: 440-444.
66. Li F, Tiede B, Massague J, Kang Y, (2007) Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 17: 3-14.